Mexico - Delayed Quote MXN

Merck & Co., Inc. (MRK.MX)

2,051.70

+27.70

+(1.37%)

At close: 1:13:00 PM CST

AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing

As its shares pop in Friday's session, pharmaceutical giant AbbVie Inc. (ABBV) posted a fourth quarter revenue beat and raised its long-term sales guidance for new drugs Skyrizi and Rinvoq by $4 billion. BMO Capital Markets managing director Evan Seigerman sits down with Seana Smith and Brad Smith on the Morning Brief to speak about AbbVie's drug research and product pipeline, especially as sales of immunosuppressant Humira fell dramatically by 49%. "They talk a lot about some of their efforts in oncology, some of their efforts in neuroscience. Yes, they had some disappointing news last year with their schizophrenia drug, but they are moving forward with other assets in Parkinson's and oncology." The senior biopharma research analyst also weighs in on Robert F. Kennedy Jr.'s secretary of the Department of Health and Human Services (HHS) confirmation hearing and how pharma stocks like Pfizer (PFE) and Merck (MRK) may be impacted: "There's been a lot of rhetoric over the past couple of days with the confirmation hearings. I've always said HHS is a very complicated organization. I'm still most focused on... the head of the FDA [Food and Drug Administration], potentially Martin McElroy. That's really important because that's kind of the critical agency for the biopharma sector." To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 5 hours ago

ABBV

PFE

MRK
Merck Halts Second PAH Drug Study Early on Strong Efficacy Results

MRK's decision to stop the late-stage HYPERION study on PAH drug Winrevair ahead of time comes after evaluating the drug's overall clinical program data.

Zacks 2 hours ago

MRK
Stocks to watch next week: Amazon, Palantir, Disney, Novo Nordisk and AstraZeneca

Earnings preview of key companies reporting next week and what to look out for.

Yahoo Finance UK 6 hours ago

MDLZ

JCI

GOOG
Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb

Novartis issued stronger guidance than Wall Street expected. Elsewhere, Eisai and Biogen’s Alzheimer’s drug will get a closer look in Europe and Daiichi Sankyo is switching CEOs.

BioPharma Dive 9 hours ago

NVS

ABBV

SNY
Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults

RAHWAY, N.J., January 31, 2025--Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults

Business Wire 9 hours ago

MRK
Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks that Jim Cramer discussed. In the episode of CNBC’s Squawk on the Street aired on the […]

Insider Monkey yesterday

MRK
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks yesterday

MRK
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis

RAHWAY, N.J., January 30, 2025--Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis

Business Wire yesterday

MRK
Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Stocks to Buy Under $100?

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best blue chip stocks to buy under $100. Blue chip stocks have long been considered the gold standard of investments, […]

Insider Monkey yesterday

MRK

^GSPC
3 Prominent US Dividend Stocks Yielding Up To 4.2%

As the U.S. stock market navigates a period of cautious anticipation ahead of the Federal Reserve's interest rate decision and major tech earnings reports, investors are keenly observing how these factors might impact broader economic trends. In this environment, dividend stocks offer a compelling option for those seeking steady income, as they can provide a buffer against market volatility while contributing to portfolio stability.

Simply Wall St. 2 days ago

ARTNA

ARTNB

MRK
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings

Biotech stocks will need to brace for political "games" Wednesday as the Senate meets to potentially confirm RFK Jr. to lead HHS.

Investor's Business Daily 2 days ago

PFE

GLAXF

GSK
Merck & Co., Inc.'s (NYSE:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

With its stock down 7.0% over the past three months, it is easy to disregard Merck (NYSE:MRK). However, a closer look...

Simply Wall St. 2 days ago

MRK
Merck & Co., Inc. (MRK): Is This Healthcare Stock A Good Buy?

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other healthcare stocks. Healthcare stocks are widely considered a cornerstone of a retirement portfolio due to their resilience, long-term growth potential, […]

Insider Monkey 2 days ago

MRK
Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization

RAHWAY, N.J., January 28, 2025--Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization

Business Wire 3 days ago

MRK
Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025?

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other Kevin O’Leary’s stock picks for 2025. Television personality, financier, and entrepreneur, Kevin O’Leary, also known as ‘Mr. Wonderful’ is recognized […]

Insider Monkey 3 days ago

MRK
Merck (MRK) Earnings Expected to Grow: Should You Buy?

Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 3 days ago

ABBV

MRK
Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?

When Merck reports fourth-quarter earnings, investors are likely to focus on the sales of its blockbuster oncology medicine, Keytruda.

Zacks 3 days ago

MRK
Is Merck & Co. (MRK) the Best Depressed Stock to Invest in Now?

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best depressed stocks to invest in now. The US stocks ended 2024 with a healthy Q4, as the equity markets were primarily […]

Insider Monkey 4 days ago

MRK

^GSPC

AMP
FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)

RAHWAY, N.J., January 27, 2025--FDA Accepts for Priority Review Merck's Application for WELIREG for Treatment of Advanced PPGL

Business Wire 4 days ago

MRK
Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’

We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC’s Squawk on the Street, Jim […]

Insider Monkey 6 days ago

MRK

Performance Overview

Return	MRK.MX	S&P 500
YTD	+1.17%	+2.26%
1-Year	-1.25%	+22.65%
3-Year	+22.54%	+36.30%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Merck & Co., Inc. (MRK.MX)

AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing

Merck Halts Second PAH Drug Study Early on Strong Efficacy Results

Stocks to watch next week: Amazon, Palantir, Disney, Novo Nordisk and AstraZeneca

Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb

Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults

Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis

Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Stocks to Buy Under $100?

3 Prominent US Dividend Stocks Yielding Up To 4.2%

The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings

Merck & Co., Inc.'s (NYSE:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Merck & Co., Inc. (MRK): Is This Healthcare Stock A Good Buy?

Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization

Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025?

Merck (MRK) Earnings Expected to Grow: Should You Buy?

Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?

Is Merck & Co. (MRK) the Best Depressed Stock to Invest in Now?

FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)

Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’

Performance Overview